DFCM
AUPH icon

Dark Forest Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Dark Forest Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-56,035
Closed -$894K – 802
2025
Q4 		$894K Buy
+56,035
New +$794K 0.04% 678
2025
Q1 		– Sell
-10,275
Closed -$92.3K – 1221
2024
Q4 		$92.3K Buy
+10,275
New +$83.8K 0.01% 864
2023
Q4 		– Sell
-115,220
Closed -$895K – 504
2023
Q3 		$895K Buy
115,220
+68,952
+149% +$674K 0.07% 466
2023
Q2 		$448K Buy
46,268
+39,317
+566% +$408K 0.04% 672
2023
Q1 		$76.2K Buy
6,951
+6,652
+2,225% +$58.6K 0.02% 745
2022
Q4 		$1.29K Buy
+299
New +$1.74K ﹤0.01% 972
2022
Q2 		– Sell
-3,743
Closed -$46K – 894
2022
Q1 		$46K Buy
3,743
+2,757
+280% +$42.6K 0.01% 623
2021
Q4 		$23K Buy
+986
New +$23.4K 0.01% 641

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dark Forest Capital Management's AUPH Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2026, closing a stake of 56,035 shares — an estimated $894K sold.

Dark Forest Capital Management first reported a position in AUPH in Q4 2021 and held it in 8 quarters. The position peaked at $895K in Q3 2023. 260 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Dark Forest Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 56,035 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $894K.
  • Dark Forest Capital Management first reported a position in Aurinia Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Dark Forest Capital Management's Aurinia Pharmaceuticals position peaked at $895K in Q3 2023.
  • 260 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.